Aloracetam
Wikipedia on Answers.com:
Top
Aloracetam
 |
|
|---|---|
| Systematic (IUPAC) name | |
| N-[2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled |
| Identifiers | |
| CAS number | 119610-26-3  |
| ATC code | None |
| PubChem | CID 178134 |
| ChemSpider | 155069 |
| UNII | U0RKZ75D0T |
| Chemical data | |
| Formula | C11H16N2O2 |
| Mol. mass | 208.257 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Aloracetam is a nootropic drug of the racetam family, developed by Aventis for the treatment of Alzheimer's disease.[1]
See also
References
- ^ Fischer F, Matthisson M, Herrling P. List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases 2004;1:50–70.
|
|||||
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Aloracetam.
Read more